Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reply to Comment on Visual Field Progression in Glaucoma Patients with Delayed Follow-Up.

American journal of ophthalmology·2026
Same author

Towards Straggler-Resilient Split Federated Learning: An Unbalanced Update Approach.

Advances in neural information processing systems·2026
Same author

Expanding the scope of <i>Mycobacterium abscessus</i> reference strains to improve pulmonary disease modeling.

bioRxiv : the preprint server for biology·2025
Same author

Age-Related Optic Nerve Optical Coherence Tomography and Optical Coherence Tomography Angiography Changes in Subjects Without Glaucoma: A 5-Year Prospective Study.

American journal of ophthalmology·2025
Same author

The impact of social determinants of health on outcomes of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemia.

Bone marrow transplantation·2025
Same author

Social Determinants Associated with Diabetic Retinopathy Awareness: National Health and Nutrition Examination Survey (2005-2008).

American journal of ophthalmology·2025
Same journal

Forging Ahead: The Need for Improved Representation in Academic Ophthalmology.

American journal of ophthalmology·2026
Same journal

Clinical Utility of Ultra-Widefield Swept-Source OCT for Intraocular Tumors: Comparison With Ultrasonography, SD-OCT, and MRI.

American journal of ophthalmology·2026
Same journal

Therapeutic Advances in Corneal Scar management: Topical Treatments, Mesenchymal Cell Therapy and Stromal Transplantation.

American journal of ophthalmology·2026
Same journal

Increased Risk for Ocular Surface Neoplasia in Recipients of Solid Organ Transplant.

American journal of ophthalmology·2026
Same journal

Aflibercept With vs Without Reduced-Fluence Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: Optical Coherence Tomography Angiographic changes from a randomized clinical trial.

American journal of ophthalmology·2026
Same journal

Posterior Segment Risk Factors for Penetrating Keratoplasty Failure.

American journal of ophthalmology·2026
See all related articles

Related Experiment Video

Updated: May 16, 2026

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

Visual Field Progression in Glaucoma Patients With Delayed Follow-Up.

Ajay Kolli1, Evan Chen2, Xinyi Xu3

  • 1From the Department of Ophthalmology (A.K., X.X., J.L., P.T., J.L., M.H., J.L., K.N., E.L., S.D.M., Y.H.), University of California, San Francisco, San Francisco, California, USA.

American Journal of Ophthalmology
|May 14, 2026
PubMed
Summary
This summary is machine-generated.

Delayed follow-up visits did not significantly increase glaucoma progression in most patients. However, longer delays were linked to higher progression odds in specific subgroups, suggesting tailored follow-up schedules may be beneficial.

More Related Videos

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Related Experiment Videos

Last Updated: May 16, 2026

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Area of Science:

  • Ophthalmology
  • Glaucoma Research
  • Clinical Practice Guidelines

Background:

  • Glaucoma management relies on regular monitoring to prevent vision loss.
  • Current follow-up intervals are provider-dependent and may not be optimized.
  • Understanding the impact of delayed follow-up (DFU) on glaucoma progression is crucial.

Purpose of the Study:

  • To investigate the association between delayed follow-up (DFU) and glaucoma progression.
  • To evaluate current glaucoma follow-up practices and their impact on disease outcomes.

Main Methods:

  • Retrospective cohort and matched case-control study of 600 glaucoma patients.
  • Analysis of Humphrey Visual Field (HVF) data and electronic health records from 2014-2023.
  • Quantified DFU metrics and analyzed associations with HVF progression using multivariable logistic regression.

Main Results:

  • No significant association found between DFU metrics and HVF progression in multivariable analyses.
  • Older age, larger cup-to-disc ratio, and unmet social needs were associated with increased progression risk.
  • In a matched case-control analysis, mean DFU >60 days was associated with higher odds of progression in patients with baseline MD < -6 dB.

Conclusions:

  • Current glaucoma follow-up intervals may be longer than necessary for many patients.
  • DFU was not a significant predictor of progression for the general glaucoma population.
  • Tailored follow-up strategies considering disease severity and individual risk factors may be warranted.